Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recom-binant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study

G.J. Veldhuis; P.H.B. Willemse; J.H. Beijnen; H. Piersma; W.T.A. van der Graaf; E.G.E. de Vries

Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recom-binant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study

G.J. Veldhuis
, P.H.B. Willemse
, J.H. Beijnen
, H. Piersma
, W.T.A. van der Graaf
, E.G.E. de Vries

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	703-709
Number of pages	7
Journal	British Journal of Cancer
Volume	75
Publication status	Published - 1997

Keywords

Medical technology
Farmacie(FARM)
Biomedische technologie en medicijnen
Public Health
Analytical chemistry
Drugmisbruik en verslaving

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{d36895bd027e42f09961e0dd338a1acf,

title = "Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recom-binant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study",

keywords = "Medical technology, Farmacie(FARM), Biomedische technologie en medicijnen, Public Health, Analytical chemistry, Drugmisbruik en verslaving",

author = "G.J. Veldhuis and P.H.B. Willemse and J.H. Beijnen and H. Piersma and \{van der Graaf\}, W.T.A. and \{de Vries\}, E.G.E.",

year = "1997",

language = "Undefined/Unknown",

volume = "75",

pages = "703--709",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

}

Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recom-binant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study. / Veldhuis, G.J.; Willemse, P.H.B.; Beijnen, J.H. et al.
In: British Journal of Cancer, Vol. 75, 1997, p. 703-709.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recom-binant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study

AU - Veldhuis, G.J.

AU - Willemse, P.H.B.

AU - Beijnen, J.H.

AU - Piersma, H.

AU - van der Graaf, W.T.A.

AU - de Vries, E.G.E.

PY - 1997

Y1 - 1997

KW - Medical technology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Public Health

KW - Analytical chemistry

KW - Drugmisbruik en verslaving

M3 - Article

SN - 0007-0920

VL - 75

SP - 703

EP - 709

JO - British Journal of Cancer

JF - British Journal of Cancer

ER -